Significance of leukocytosis after cardiac device implantation

Christine Tompkins, Alan Cheng, Jeffrey A. Brinker, Joseph E. Marine, Saman Nazarian, David D. Spragg, Sunil Sinha, Henry Halperin, Gordon F. Tomaselli, Ronald D. Berger, Hugh Calkins, Charles Henrikson

    Research output: Contribution to journalArticle

    6 Citations (Scopus)

    Abstract

    Infection remains a feared complication after cardiac device implantation. Whether early postprocedural leukocytosis, a recognized marker of infection, is an indicator of impending infection is unclear and was the focus of this study. A retrospective chart review of consecutive patients who underwent implantable cardioverter defibrillator or pacemaker implantation was performed. The association between change in white blood cell (WBC) count and development of infection after device implantation was assessed. Infection was defined as pocket or lead infection or as bacteremia or sepsis 15,000/μl. Subjects with significant leukocytosis were younger (mean age 61.9 ± 16.5 vs 65.6 ± 15.1 years, p

    Original languageEnglish (US)
    Pages (from-to)1608-1612
    Number of pages5
    JournalAmerican Journal of Cardiology
    Volume111
    Issue number11
    DOIs
    StatePublished - Jun 1 2013

    Fingerprint

    Leukocytosis
    Equipment and Supplies
    Infection
    Implantable Defibrillators
    Bacteremia
    Leukocyte Count
    Sepsis

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Tompkins, C., Cheng, A., Brinker, J. A., Marine, J. E., Nazarian, S., Spragg, D. D., ... Henrikson, C. (2013). Significance of leukocytosis after cardiac device implantation. American Journal of Cardiology, 111(11), 1608-1612. https://doi.org/10.1016/j.amjcard.2013.01.334

    Significance of leukocytosis after cardiac device implantation. / Tompkins, Christine; Cheng, Alan; Brinker, Jeffrey A.; Marine, Joseph E.; Nazarian, Saman; Spragg, David D.; Sinha, Sunil; Halperin, Henry; Tomaselli, Gordon F.; Berger, Ronald D.; Calkins, Hugh; Henrikson, Charles.

    In: American Journal of Cardiology, Vol. 111, No. 11, 01.06.2013, p. 1608-1612.

    Research output: Contribution to journalArticle

    Tompkins, C, Cheng, A, Brinker, JA, Marine, JE, Nazarian, S, Spragg, DD, Sinha, S, Halperin, H, Tomaselli, GF, Berger, RD, Calkins, H & Henrikson, C 2013, 'Significance of leukocytosis after cardiac device implantation', American Journal of Cardiology, vol. 111, no. 11, pp. 1608-1612. https://doi.org/10.1016/j.amjcard.2013.01.334
    Tompkins C, Cheng A, Brinker JA, Marine JE, Nazarian S, Spragg DD et al. Significance of leukocytosis after cardiac device implantation. American Journal of Cardiology. 2013 Jun 1;111(11):1608-1612. https://doi.org/10.1016/j.amjcard.2013.01.334
    Tompkins, Christine ; Cheng, Alan ; Brinker, Jeffrey A. ; Marine, Joseph E. ; Nazarian, Saman ; Spragg, David D. ; Sinha, Sunil ; Halperin, Henry ; Tomaselli, Gordon F. ; Berger, Ronald D. ; Calkins, Hugh ; Henrikson, Charles. / Significance of leukocytosis after cardiac device implantation. In: American Journal of Cardiology. 2013 ; Vol. 111, No. 11. pp. 1608-1612.
    @article{544fda03b20c405fa0d443fa48a08abc,
    title = "Significance of leukocytosis after cardiac device implantation",
    abstract = "Infection remains a feared complication after cardiac device implantation. Whether early postprocedural leukocytosis, a recognized marker of infection, is an indicator of impending infection is unclear and was the focus of this study. A retrospective chart review of consecutive patients who underwent implantable cardioverter defibrillator or pacemaker implantation was performed. The association between change in white blood cell (WBC) count and development of infection after device implantation was assessed. Infection was defined as pocket or lead infection or as bacteremia or sepsis 15,000/μl. Subjects with significant leukocytosis were younger (mean age 61.9 ± 16.5 vs 65.6 ± 15.1 years, p",
    author = "Christine Tompkins and Alan Cheng and Brinker, {Jeffrey A.} and Marine, {Joseph E.} and Saman Nazarian and Spragg, {David D.} and Sunil Sinha and Henry Halperin and Tomaselli, {Gordon F.} and Berger, {Ronald D.} and Hugh Calkins and Charles Henrikson",
    year = "2013",
    month = "6",
    day = "1",
    doi = "10.1016/j.amjcard.2013.01.334",
    language = "English (US)",
    volume = "111",
    pages = "1608--1612",
    journal = "American Journal of Cardiology",
    issn = "0002-9149",
    publisher = "Elsevier Inc.",
    number = "11",

    }

    TY - JOUR

    T1 - Significance of leukocytosis after cardiac device implantation

    AU - Tompkins, Christine

    AU - Cheng, Alan

    AU - Brinker, Jeffrey A.

    AU - Marine, Joseph E.

    AU - Nazarian, Saman

    AU - Spragg, David D.

    AU - Sinha, Sunil

    AU - Halperin, Henry

    AU - Tomaselli, Gordon F.

    AU - Berger, Ronald D.

    AU - Calkins, Hugh

    AU - Henrikson, Charles

    PY - 2013/6/1

    Y1 - 2013/6/1

    N2 - Infection remains a feared complication after cardiac device implantation. Whether early postprocedural leukocytosis, a recognized marker of infection, is an indicator of impending infection is unclear and was the focus of this study. A retrospective chart review of consecutive patients who underwent implantable cardioverter defibrillator or pacemaker implantation was performed. The association between change in white blood cell (WBC) count and development of infection after device implantation was assessed. Infection was defined as pocket or lead infection or as bacteremia or sepsis 15,000/μl. Subjects with significant leukocytosis were younger (mean age 61.9 ± 16.5 vs 65.6 ± 15.1 years, p

    AB - Infection remains a feared complication after cardiac device implantation. Whether early postprocedural leukocytosis, a recognized marker of infection, is an indicator of impending infection is unclear and was the focus of this study. A retrospective chart review of consecutive patients who underwent implantable cardioverter defibrillator or pacemaker implantation was performed. The association between change in white blood cell (WBC) count and development of infection after device implantation was assessed. Infection was defined as pocket or lead infection or as bacteremia or sepsis 15,000/μl. Subjects with significant leukocytosis were younger (mean age 61.9 ± 16.5 vs 65.6 ± 15.1 years, p

    UR - http://www.scopus.com/inward/record.url?scp=84877792607&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84877792607&partnerID=8YFLogxK

    U2 - 10.1016/j.amjcard.2013.01.334

    DO - 10.1016/j.amjcard.2013.01.334

    M3 - Article

    VL - 111

    SP - 1608

    EP - 1612

    JO - American Journal of Cardiology

    JF - American Journal of Cardiology

    SN - 0002-9149

    IS - 11

    ER -